Veeva continues rapid pace of innovation to deliver new levels of speed and compliance in content management for life sciences industry
PLEASANTON, CA – April 28, 2016 — Veeva Systems (NYSE: VEEV) introduced innovative features in its newest release of Veeva Vault, version 14. The Veeva Vault platform and suite of enterprise applications empower life sciences companies to streamline their business processes across an increasingly broad ecosystem of internal and external stakeholders.
Today, many life sciences companies use a multitude of disconnected, complex systems to manage critical content. This fragmented approach leads to process inefficiencies and increased regulatory risk each time they develop and commercialize a new product.
Veeva counters this approach with Veeva Vault, a cloud-based content management platform and suite of applications that provide a single source of truth to reduce complexity and increase business agility. Veeva Vault not only manages regulated documents, but also tracks critical information for product development and commercialization processes. Only Veeva manages this unique combination of documents and information to provide deeper insight and improve efficiency.
Powerful new capabilities now available in Veeva Vault allow life sciences companies to:
• More accurately plan and track documents – Expected Document Lists provides a comprehensive plan for expected documents that ensures better accuracy of document planning and tracking for clinical and commercial content. Gain full visibility into the status of document collection, planning, and packaging at all times to measure the completeness of projects. Additionally, share an accurate list of expected documents at any time with all key stakeholders.
• Provide better insight – Document Relationship Reports provide insight into where and how enterprise content is being re-used by internal and external stakeholders. Save time and money by leveraging existing content rather than recreating it. Also, quickly and accurately perform global impact assessments every time a piece of content changes or needs to change.
• Simplify secure access for internal and external collaborators – Dynamic Access Control simplifies security and access administration to reduce the risk of errors and improve compliance. Make enterprise-class security easy with a robust, rules-based security model that automates access to documents based on information about the document and the user.
• Improve business processes – Major enhancements are available across all Veeva Vault applications – including clinical, quality, regulatory, medical, and commercial – to increase business agility, speed time-to-market, and better meet regulatory requirements.
“We continue to innovate at a rapid pace to deliver new levels of enterprise speed and compliance for our customers to improve their global business processes,” said Jennifer Goldsmith, senior vice president of Veeva Vault. “Veeva Vault is enabling life sciences companies to lower the cost, complexity, time, and compliance risk of developing and bringing new products to market.”
Today, 18 of the 20 largest pharmaceutical companies use Veeva Vault applications to streamline their global business processes. One fast-growing global biopharmaceutical company, Sucampo Pharmaceuticals (NASDAQ:SCMP), recently standardized on the Veeva Vault platform and suite of applications to provide a unified foundation for content and information management. See below for more on this announcement.
PLEASANTON, CA – April 28, 2016 — Veeva Systems (NYSE: VEEV) introduced innovative features in its newest release of Veeva Vault, version 14. The Veeva Vault platform and suite of enterprise applications empower life sciences companies to streamline their business processes across an increasingly broad ecosystem of internal and external stakeholders.
Today, many life sciences companies use a multitude of disconnected, complex systems to manage critical content. This fragmented approach leads to process inefficiencies and increased regulatory risk each time they develop and commercialize a new product.
Veeva counters this approach with Veeva Vault, a cloud-based content management platform and suite of applications that provide a single source of truth to reduce complexity and increase business agility. Veeva Vault not only manages regulated documents, but also tracks critical information for product development and commercialization processes. Only Veeva manages this unique combination of documents and information to provide deeper insight and improve efficiency.
Powerful new capabilities now available in Veeva Vault allow life sciences companies to:
• More accurately plan and track documents – Expected Document Lists provides a comprehensive plan for expected documents that ensures better accuracy of document planning and tracking for clinical and commercial content. Gain full visibility into the status of document collection, planning, and packaging at all times to measure the completeness of projects. Additionally, share an accurate list of expected documents at any time with all key stakeholders.
• Provide better insight – Document Relationship Reports provide insight into where and how enterprise content is being re-used by internal and external stakeholders. Save time and money by leveraging existing content rather than recreating it. Also, quickly and accurately perform global impact assessments every time a piece of content changes or needs to change.
• Simplify secure access for internal and external collaborators – Dynamic Access Control simplifies security and access administration to reduce the risk of errors and improve compliance. Make enterprise-class security easy with a robust, rules-based security model that automates access to documents based on information about the document and the user.
• Improve business processes – Major enhancements are available across all Veeva Vault applications – including clinical, quality, regulatory, medical, and commercial – to increase business agility, speed time-to-market, and better meet regulatory requirements.
“We continue to innovate at a rapid pace to deliver new levels of enterprise speed and compliance for our customers to improve their global business processes,” said Jennifer Goldsmith, senior vice president of Veeva Vault. “Veeva Vault is enabling life sciences companies to lower the cost, complexity, time, and compliance risk of developing and bringing new products to market.”
Today, 18 of the 20 largest pharmaceutical companies use Veeva Vault applications to streamline their global business processes. One fast-growing global biopharmaceutical company, Sucampo Pharmaceuticals (NASDAQ:SCMP), recently standardized on the Veeva Vault platform and suite of applications to provide a unified foundation for content and information management. See below for more on this announcement.
